SCHEMBL834057

SCHEMBL834057

CCC(F)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1033255 1.00
SCHEMBL1031752 1.00
SCHEMBL1031233 0.75
SCHEMBL1030118 0.75
SCHEMBL833960 0.75
SCHEMBL834166 0.71
SCHEMBL833534 0.69
SCHEMBL1577159 0.69
SCHEMBL13719164 0.69
SCHEMBL7754996 0.68 MAPT (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111479574-B Compounds for the treatment and prevention of extracellular histone mediated pathologies 澳大利亚国立大学 2024-02-09 CN disclosed
CN-117462563-A Compounds for the treatment and prevention of extracellular histone mediated pathologies 澳大利亚国立大学 2024-01-30 CN disclosed
CN-117427084-A Compounds for the treatment and prevention of extracellular histone mediated pathologies 澳大利亚国立大学 2024-01-23 CN disclosed
CN-114732822-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-06-30 CN disclosed
CN-114681472-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-06-30 CN disclosed
CN-114732823-B Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2023-05-23 CN disclosed
CN-218929287-U Automobile foot pad with lamp strip 四川立予希科技有限公司 2023-04-28 CN disclosed
CN-114732823-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-12 CN disclosed
CN-114732822-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-12 CN disclosed
CN-114681472-A Application of glucosamine and derivatives thereof as antiviral drugs 中国人民解放军军事科学院军事医学研究院 2022-07-01 CN disclosed
US-5273998-A Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1993-12-28 US disclosed
US-5177216-A DIASTEREOMERIC ESTER COMPOUND USEFUL AS AN INTERMEDIATE IN THE MAKING OF AN OPTICALLY ACTIVE 3,4-DIHYDRO-3,4-EPOXY-2H-1-BENZOPYRAN COMPOUND YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1993-01-05 US disclosed
US-5162553-A Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds and intermediates therefor YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-11-10 US disclosed
US-5066816-A PROCESSES FOR PREPARING OPTICALLY ACTIVE 3,4-DIHYDRO-3,4-EPOXY-2H-1-BENZOPYRAN COMPOUNDS AND INTERMEDIATES THEREFOR YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-11-19 US disclosed
EP-0456266-A1 Method for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds, intermediates therefor and uses thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-11-13 EP disclosed
EP-0239129-B1 HYDROQUINOLINE COMPOUNDS, COMPOSITIONS CONTAINING SAME AND PROCESSES FOR PREPARING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-09-25 EP disclosed
US-4963566-A ANTIULCER AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-10-16 US disclosed
EP-0386640-A2 Processes for preparing optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compounds and intermediates therefor YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1990-09-12 EP disclosed
EP-0239129-A2 Hydroquinoline compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-09-30 EP disclosed
EP-0204416-A2 Light-sensitive silver halide color photographic material KONICA CORPORATION (JP) 1986-12-10 EP disclosed